AstraZeneca has scored with Tezspire in a third inflammatory disease in a Phase 3 trial. Developed with Amgen, Tezspire met both co-primary endpoints in the late-stage trial for eosinophilic esophagitis
Dr Reddy’s Laboratories has secured a key approval for its arthritis treatment portfolio in India. The company received marketing approval for its abatacept biosimilar from the Central Drugs Standard Control Organisation (CDSCO).
India’s new Medical Device Rule could increase compliance costs for manufacturers. The rule requires makers to disclose details of outsourced sterilization facilities on device labels. The medical device rule is aimed at improving traceability...
Calcium Gluconate has become the latest addition to Glenmark Pharmaceuticals' U.S. injectable portfolio, this move supports its strategy to build a differentiated, sustainable U.S. injectables business focused on institutional demand
Mankind Pharma has signed an in-licensing deal with China’s Chongqing Chenan Biopharmaceutical to commercialise two insulin analogues in India and strengthen its diabetes portfolio.
Ophthalmology is becoming a stronger specialty-care focus for Lupin as the company expands its European eye-care business through VISUfarma
Glenmark’s latest USFDA approval covers Fluticasone Propionate Nasal Spray. The FDA has determined the product to be bioequivalent and therapeutically equivalent to Flonase Nasal Spray
India’s heart-lung machine market is set for a major shift as a homegrown device gains key regulatory approvals. The heart-lung machine developed by Mediyant Technologies has received USFDA 510(k) clearance and CDSCO approval.
Indian skincare is entering a new growth phase as established consumer companies move deeper into premium and science-backed beauty
Hearzap today announced the successful completion of its acquisition of Amplifon India's hearing healthcare business. The acquisition took place after definitive agreement announced in May 2026, marking one of the most significant developments...
.jpg)
, CDSCO.jpg)